Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

Articles published in
Curr Opin Pulm Med
    January 2021
  1. BOULET LP, Cote A, Abd-Elaziz K, Gauvreau G, et al
    Allergen bronchoprovocation test: an important research tool supporting precision medicine.
    Curr Opin Pulm Med. 2021;27:15-22.
    >> Share

    October 2020
  2. DIAMANT Z, Hanania NA
    Dealing with asthma during the turbulent times of coronavirus disease-2019.
    Curr Opin Pulm Med. 2020 Oct 21. doi: 10.1097/MCP.0000000000000745.
    >> Share

  3. RAMASWAMY US, Patel VA, Lee SE
    Managing chronic rhinosinusitis in severe asthma.
    Curr Opin Pulm Med. 2020 Oct 21. doi: 10.1097/MCP.0000000000000741.
    >> Share

  4. BLAKE KV
    Telemedicine and adherence monitoring in children with asthma.
    Curr Opin Pulm Med. 2020 Oct 21. doi: 10.1097/MCP.0000000000000739.
    >> Share

  5. ASSAF SM, Tarasevych SP, Diamant Z, Hanania NA, et al
    Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.
    Curr Opin Pulm Med. 2020 Oct 16. doi: 10.1097/MCP.0000000000000744.
    >> Share

  6. ABD-ELAZIZ K, Jesenak M, Vasakova M, Diamant Z, et al
    Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases.
    Curr Opin Pulm Med. 2020 Oct 16. doi: 10.1097/MCP.0000000000000743.
    >> Share

  7. KAO CC, Hanania NA, Parulekar AD
    The impact of fungal allergic sensitization on asthma.
    Curr Opin Pulm Med. 2020 Oct 6. doi: 10.1097/MCP.0000000000000740.
    >> Share

    September 2020
  8. WU TD
    Diabetes, insulin resistance, and asthma: a review of potential links.
    Curr Opin Pulm Med. 2020 Sep 29. doi: 10.1097/MCP.0000000000000738.
    >> Share

  9. QUIRCE S, Dominguez-Ortega J, Luna JA
    Novel approaches in occupational asthma diagnosis and management.
    Curr Opin Pulm Med. 2020 Sep 21. doi: 10.1097/MCP.0000000000000737.
    >> Share

    July 2020
  10. HARDER EM, Waxman AB
    Clinical trials in group 3 pulmonary hypertension.
    Curr Opin Pulm Med. 2020 Jul 9. doi: 10.1097/MCP.0000000000000694.
    >> Share

    March 2020
  11. MCDONALD CF
    Eosinophils in chronic obstructive pulmonary disease: are they just another biomarker?
    Curr Opin Pulm Med. 2020;26:169-174.
    >> Share

  12. RATARASARN K, Kundu A
    Yoga and Tai Chi: a mind-body approach in managing respiratory symptoms in obstructive lung diseases.
    Curr Opin Pulm Med. 2020;26:186-192.
    >> Share

  13. WILES SP, Aboussouan LS, Mireles-Cabodevila E
    Noninvasive positive pressure ventilation in stable patients with COPD.
    Curr Opin Pulm Med. 2020;26:175-185.
    >> Share

  14. ALBITAR HAH, Iyer VN
    Adherence to Global Initiative for Chronic Obstructive Lung Disease guidelines in the real world: current understanding, barriers, and solutions.
    Curr Opin Pulm Med. 2020;26:149-154.
    >> Share

  15. SINGH D, Long G, Cancado JED, Higham A, et al
    Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician.
    Curr Opin Pulm Med. 2020;26:162-168.
    >> Share

    February 2020
  16. SPECJALSKI K, Niedoszytko M
    MicroRNAs: future biomarkers and targets of therapy in asthma?
    Curr Opin Pulm Med. 2020 Feb 25. doi: 10.1097/MCP.0000000000000673.
    >> Share

    January 2020
  17. CHRISTENSON SA
    The role of genomic profiling in identifying molecular phenotypes in obstructive lung diseases.
    Curr Opin Pulm Med. 2020;26:84-89.
    >> Share

  18. ULRIK CS, Vijverberg S, Hanania NA, Diamant Z, et al
    Precision medicine and treatable traits in chronic airway diseases - where do we stand?
    Curr Opin Pulm Med. 2020;26:33-39.
    >> Share

  19. GAUVREAU GM, White L, Davis BE
    Anti-alarmin approaches entering clinical trials.
    Curr Opin Pulm Med. 2020;26:69-76.
    >> Share

    November 2019
  20. DIAMANT Z, van den Berge M, Hanania NA
    Asthma: a modifiable disease on a crossroad.
    Curr Opin Pulm Med. 2019 Nov 12. doi: 10.1097/MCP.0000000000000650.
    >> Share

  21. PITZNER-FABRICIUS A, Toennesen LL, Backer V
    Can training induce inflammatory control in asthma, or is it symptom control only?
    Curr Opin Pulm Med. 2019 Nov 12. doi: 10.1097/MCP.0000000000000648.
    >> Share

  22. BONTINCK A, Maes T, Joos G
    Asthma and air pollution: recent insights in pathogenesis and clinical implications.
    Curr Opin Pulm Med. 2019 Nov 12. doi: 10.1097/MCP.0000000000000644.
    >> Share

  23. VENKATA AN
    Asthma-COPD overlap: review of diagnosis and management.
    Curr Opin Pulm Med. 2019 Nov 9. doi: 10.1097/MCP.0000000000000649.
    >> Share

  24. VAN DER VEEN TA, de Groot LES, Melgert BN
    The different faces of the macrophage in asthma.
    Curr Opin Pulm Med. 2019 Nov 7. doi: 10.1097/MCP.0000000000000647.
    >> Share

  25. SANCHEZ-GARCIA S, Rial MJ, Dominguez-Ortega J
    Long and winding road: from infant wheeze to adult asthma.
    Curr Opin Pulm Med. 2019 Nov 4. doi: 10.1097/MCP.0000000000000643.
    >> Share

    October 2019
  26. BAHMER T, Sand JMB, Weckmann M
    Lost in transition: biomarkers of remodeling in patients with asthma.
    Curr Opin Pulm Med. 2019 Oct 24. doi: 10.1097/MCP.0000000000000641.
    >> Share

  27. LU KD, Forno E
    Exercise and lifestyle changes in pediatric asthma.
    Curr Opin Pulm Med. 2019 Oct 24. doi: 10.1097/MCP.0000000000000636.
    >> Share

  28. ROGLIANI P, Sforza M, Calzetta L
    The impact of comorbidities on severe asthma.
    Curr Opin Pulm Med. 2019 Oct 21. doi: 10.1097/MCP.0000000000000640.
    >> Share

  29. SLISZ T, Vasakova M
    The burden of corticosteroid overload in severe and difficult to treat asthma: how to reduce this?
    Curr Opin Pulm Med. 2019 Oct 9. doi: 10.1097/MCP.0000000000000635.
    >> Share

    September 2019
  30. VIJVERBERG SJH, Brinkman P, Rutjes NWP, Maitland-van der Zee AH, et al
    Precision medicine in severe pediatric asthma: opportunities and challenges.
    Curr Opin Pulm Med. 2019 Sep 30. doi: 10.1097/MCP.0000000000000633.
    >> Share

  31. KOZIK A, Huang YJ
    Ecological interactions in asthma: from environment to microbiota and immune responses.
    Curr Opin Pulm Med. 2019 Sep 24. doi: 10.1097/MCP.0000000000000632.
    >> Share

    March 2019
  32. CHANG-MACCHIU P, Traversi L, Polverino E
    Bronchiectasis phenotypes.
    Curr Opin Pulm Med. 2019 Mar 18. doi: 10.1097/MCP.0000000000000569.
    >> Share

  33. DUNLAP DG, Semaan R, Riley CM, Sciurba FC, et al
    Bronchoscopic device intervention in chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2019;25:201-210.
    >> Share

  34. WANG J, Cao B
    Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.
    Curr Opin Pulm Med. 2019;25:158-164.
    >> Share

  35. MANNINO DM
    Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise.
    Curr Opin Pulm Med. 2019;25:144-149.
    >> Share

  36. MOON JY, Sin DD
    Inhaled corticosteroids and fractures in chronic obstructive pulmonary disease: current understanding and recommendations.
    Curr Opin Pulm Med. 2019;25:165-172.
    >> Share

  37. BURKES RM, Drummond MB
    Initiating drug therapy in early stage chronic obstructive pulmonary disease: does it impact the course and outcome?
    Curr Opin Pulm Med. 2019;25:132-137.
    >> Share

  38. AMARIEI DE, Reed RM
    The role of statins in chronic obstructive pulmonary disease: is cardiovascular disease the common denominator?
    Curr Opin Pulm Med. 2019;25:173-178.
    >> Share

  39. CHAN HP, Lim TK
    Procalcitonin and antibiotics in moderate-severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use.
    Curr Opin Pulm Med. 2019;25:150-157.
    >> Share

    February 2019
  40. RATHNAYAKE SNH, Van den Berge M, Faiz A
    Genetic profiling for disease stratification in chronic obstructive pulmonary disease and asthma.
    Curr Opin Pulm Med. 2019 Feb 11. doi: 10.1097/MCP.0000000000000568.
    >> Share

    January 2019
  41. KOCUREK EG, Jagana R
    Noncystic fibrosis bronchiectasis management: opportunities and challenges.
    Curr Opin Pulm Med. 2019 Jan 10. doi: 10.1097/MCP.0000000000000562.
    >> Share

  42. BRINKMAN P, Zee AM, Wagener AH
    Breathomics and treatable traits for chronic airway diseases.
    Curr Opin Pulm Med. 2019;25:94-100.
    >> Share

    November 2018
  43. PEREZ-MIRANDA J, Traversi L, Polverino E
    Bronchiectasis in severe asthma: a distinct phenotype?
    Curr Opin Pulm Med. 2018 Nov 16. doi: 10.1097/MCP.0000000000000542.
    >> Share

  44. PAVORD ID
    Oral corticosteroid-dependent asthma: current knowledge and future needs.
    Curr Opin Pulm Med. 2018 Nov 16. doi: 10.1097/MCP.0000000000000541.
    >> Share

  45. ROMAN-RODRIGUEZ M, Metting E, Gacia-Pardo M, Kocks J, et al
    Wrong inhalation technique is associated to poor asthma clinical outcomes. Is there room for improvement?
    Curr Opin Pulm Med. 2018 Nov 15. doi: 10.1097/MCP.0000000000000540.
    >> Share

  46. BOULET LP, Hanania NA
    The many faces of asthma-chronic obstructive pulmonary disease overlap.
    Curr Opin Pulm Med. 2018 Nov 15. doi: 10.1097/MCP.0000000000000547.
    >> Share

  47. PELOZA DL, Jackson DJ
    Strategies to prevent exacerbations of childhood asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000539.
    >> Share

  48. ERJEFALT JS
    Unravelling the complexity of tissue inflammation in uncontrolled and severe asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000536.
    >> Share

  49. SEYS SF, Lokwani R, Simpson JL, Bullens DMA, et al
    New insights in neutrophilic asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000543.
    >> Share

  50. DIAMANT Z, Aalders W, Parulekar A, Bjermer L, et al
    Targeting lipid mediators in asthma: time for reappraisal.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000544.
    >> Share

  51. ROBIJN AL, Murphy VE, Gibson PG
    Recent developments in asthma in pregnancy.
    Curr Opin Pulm Med. 2018 Nov 6. doi: 10.1097/MCP.0000000000000538.
    >> Share

  52. VAN DEN BERGE M, Tasena H
    Role of microRNAs and exosomes in asthma.
    Curr Opin Pulm Med. 2018 Nov 1. doi: 10.1097/MCP.0000000000000532.
    >> Share

  53. GRACE J, Mohan A, Lugogo NL
    Obesity and adult asthma: diagnostic and management challenges.
    Curr Opin Pulm Med. 2018 Nov 1. doi: 10.1097/MCP.0000000000000531.
    >> Share

    October 2018
  54. LANG JE
    Obesity and childhood asthma.
    Curr Opin Pulm Med. 2018 Oct 16. doi: 10.1097/MCP.0000000000000537.
    >> Share

  55. HERRERA-LUIS E, Hernandez-Pacheco N, Vijverberg SJ, Flores C, et al
    Role of genomics in asthma exacerbations.
    Curr Opin Pulm Med. 2018 Oct 16. doi: 10.1097/MCP.0000000000000533.
    >> Share

  56. QUIRCE S, Sastre J
    Occupational asthma: clinical phenotypes, biomarkers, and management.
    Curr Opin Pulm Med. 2018 Oct 12. doi: 10.1097/MCP.0000000000000535.
    >> Share

    September 2018
  57. KAVANAGH J, Jackson DJ, Kent BD
    Sleep and asthma.
    Curr Opin Pulm Med. 2018 Sep 7. doi: 10.1097/MCP.0000000000000526.
    >> Share

    May 2018
  58. VAN MOORSEL CHM
    Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2018;24:309-317.
    >> Share

    March 2018
  59. HATIPOGLU U, Stoller JK
    Supplemental oxygen in patients with stable chronic obstructive pulmonary disease: evidence from Nocturnal Oxygen Treatment Trial to Long-term Oxygen Treatment Trial.
    Curr Opin Pulm Med. 2018;24:179-186.
    >> Share

  60. BARRECHEGUREN M, Bourbeau J
    Self-management strategies in chronic obstructive pulmonary disease: a first step toward personalized medicine.
    Curr Opin Pulm Med. 2018;24:191-198.
    >> Share

  61. DAS N, Topalovic M, Janssens W
    Artificial intelligence in diagnosis of obstructive lung disease: current status and future potential.
    Curr Opin Pulm Med. 2018;24:117-123.
    >> Share

  62. KAKKERA K, Padala KP, Kodali M, Padala PR, et al
    Association of chronic obstructive pulmonary disease with mild cognitive impairment and dementia.
    Curr Opin Pulm Med. 2018;24:173-178.
    >> Share

  63. IYER VN
    Low-dose oxygen therapy in COPD patients: are there any radiation-like risks?
    Curr Opin Pulm Med. 2018;24:187-190.
    >> Share

  64. SIDDIQUI FM, Diamond JM
    Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions.
    Curr Opin Pulm Med. 2018;24:199-204.
    >> Share

  65. BISWAS A, Mehta HJ, Folch EE
    Chronic obstructive pulmonary disease and lung cancer: inter-relationships.
    Curr Opin Pulm Med. 2018;24:152-160.
    >> Share

  66. PRESS VG, Konetzka RT, White SR
    Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.
    Curr Opin Pulm Med. 2018;24:138-146.
    >> Share

  67. SPENCER L
    Pulmonary rehabilitation for patients with acute chronic obstructive pulmonary disease exacerbations: is the evidence strengthening?
    Curr Opin Pulm Med. 2018;24:147-151.
    >> Share

  68. KRISHNAN JK, Martinez FJ
    Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps.
    Curr Opin Pulm Med. 2018;24:124-129.
    >> Share

  69. DEAS SD, Huprikar N
    Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and Safety of fixed dose combination treatments in the setting of recent guideline updates.
    Curr Opin Pulm Med. 2018;24:130-137.
    >> Share

    January 2018
  70. FINGLETON J, Hardy J, Beasley R
    Treatable traits of chronic airways disease.
    Curr Opin Pulm Med. 2018;24:24-31.
    >> Share

    December 2017
  71. CHATTERJEE K, Tarawneh AR, Alam S
    Out of proportion pulmonary hypertension in obstructive lung diseases.
    Curr Opin Pulm Med. 2017 Dec 18. doi: 10.1097/MCP.0000000000000457.
    >> Share

    November 2017
  72. CARPAIJ OA, van den Berge M
    The asthma-obesity relationship: underlying mechanisms and treatment implications.
    Curr Opin Pulm Med. 2017 Nov 23. doi: 10.1097/MCP.0000000000000446.
    >> Share

    October 2017
  73. KOCKS JWH, Seys SF, van Duin TS, Diamant Z, et al
    Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?
    Curr Opin Pulm Med. 2017 Oct 27. doi: 10.1097/MCP.0000000000000447.
    >> Share

  74. AL-SAJEE D, Oliveria JP, Sehmi R, Gauvreau GM, et al
    Antialarmins for treatment of asthma: future perspectives.
    Curr Opin Pulm Med. 2017 Oct 27. doi: 10.1097/MCP.0000000000000443.
    >> Share

  75. NYENHUIS SM, Apter AJ, Schatz M, Krishnan JA, et al
    Comparative effectiveness trials in asthma - how will I recognize one?
    Curr Opin Pulm Med. 2017 Oct 25. doi: 10.1097/MCP.0000000000000442.
    >> Share

  76. BOULET LP
    Airway remodeling in asthma: update on mechanisms and therapeutic approaches.
    Curr Opin Pulm Med. 2017 Oct 25. doi: 10.1097/MCP.0000000000000441.
    >> Share

  77. PITE H, Morais-Almeida M, Rocha SM
    Metabolomics in asthma: where do we stand?
    Curr Opin Pulm Med. 2017 Oct 20. doi: 10.1097/MCP.0000000000000437.
    >> Share

  78. HUMBERT M, Busse W, Hanania NA
    Controversies and opportunities in severe asthma.
    Curr Opin Pulm Med. 2017 Oct 20. doi: 10.1097/MCP.0000000000000438.
    >> Share

  79. HANANIA NA, Diamant Z
    The road to precision medicine in asthma: challenges and opportunities.
    Curr Opin Pulm Med. 2017 Oct 17. doi: 10.1097/MCP.0000000000000444.
    >> Share

  80. BONINI M, Usmani OS
    Novel methods for device and adherence monitoring in asthma.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000439.
    >> Share

  81. PARULEKAR AD, Kao CC, Diamant Z, Hanania NA, et al
    Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000436.
    >> Share

  82. CHUNG KF
    Precision medicine in asthma: linking phenotypes to targeted treatments.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000434.
    >> Share

  83. BRAIDO F, Baiardini I, Canonica GW
    Patient-reported outcomes in asthma clinical trials.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000440.
    >> Share

    March 2017
  84. ALTER A, Aboussouan LS, Mireles-Cabodevila E
    Neuromuscular weakness in chronic obstructive pulmonary disease: chest wall, diaphragm, and peripheral muscle contributions.
    Curr Opin Pulm Med. 2017;23:129-138.
    >> Share

  85. KWO E, Christiani D
    The role of gene-environment interplay in occupational and environmental diseases: current concepts and knowledge gaps.
    Curr Opin Pulm Med. 2017;23:173-176.
    >> Share

  86. HARRINGTON SE, Rogers E, Davis M
    Palliative care and chronic obstructive pulmonary disease: where the lines meet.
    Curr Opin Pulm Med. 2017;23:154-160.
    >> Share

  87. TSAI SC
    Chronic obstructive pulmonary disease and sleep related disorders.
    Curr Opin Pulm Med. 2017;23:124-128.
    >> Share

  88. RAGHAVAN D, Varkey A, Bartter T
    Chronic obstructive pulmonary disease: the impact of gender.
    Curr Opin Pulm Med. 2017;23:117-123.
    >> Share

  89. HANSON C, LeVan T
    Obesity and chronic obstructive pulmonary disease: recent knowledge and future directions.
    Curr Opin Pulm Med. 2017;23:149-153.
    >> Share

  90. SEHGAL IS, Dhooria S, Agarwal R
    Chronic obstructive pulmonary disease and malnutrition in developing countries.
    Curr Opin Pulm Med. 2017;23:139-148.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016